Milestone Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference
MONTREAL and CHARLOTTE, N.C., Nov. 21, 2018
MONTREAL and CHARLOTTE, N.C., Nov. 21, 2018 /PRNewswire/ -- Milestone Pharmaceuticals USA, Inc. today announced that Joseph G. Oliveto, President and Chief Executive Officer, will present at the 30th Annual Piper Jaffray Healthcare Conference in New York on Tuesday, November 27, 2018 at 9:50 a.m. Eastern Time.
About Milestone Pharmaceuticals
Milestone, headquartered in Montreal, Canada with a U.S. subsidiary in Charlotte, N.C., is a late-stage biopharmaceutical company focused on developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions.
For more information, visit www.milestonepharma.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-the-30th-annual-piper-jaffray-healthcare-conference-300754024.html
SOURCE Milestone Pharmaceuticals USA, Inc.